Evidence map›Paper›PMID 25047118›Full record

ArticleNature communications2014

Development of pro-apoptotic peptides as potential therapy for peritoneal endometriosis.

K Sugihara, Y Kobayashi, A Suzuki, N Tamura, K Motamedchaboki, C-T Huang, T O Akama, J Pecotte, P Frost, C Bauer and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Nature communications, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Review
  3. N-Myc and STAT Interactor is an Endometriosis Suppressor.International journal of molecular sciences · 2024
    Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

K SugiharaDepartment of Obstetrics and Gynecology, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu, Shizuoka 431-3192, Japan.
Y KobayashiTumor Microenvironment, Cancer Center, Sanford-Burnham Medical Research Institute, 10901 North Torrey Pines Road, La Jolla, California 92037, USA.
A SuzukiDepartment of Obstetrics and Gynecology, Keio University School of Medicine, Shinanomachi 35, Tokyo 160-8582, Japan.
N TamuraTumor Microenvironment, Cancer Center, Sanford-Burnham Medical Research Institute, 10901 North Torrey Pines Road, La Jolla, California 92037, USA.
K MotamedchabokiTumor Microenvironment, Cancer Center, Sanford-Burnham Medical Research Institute, 10901 North Torrey Pines Road, La Jolla, California 92037, USA.
C-T HuangTumor Microenvironment, Cancer Center, Sanford-Burnham Medical Research Institute, 10901 North Torrey Pines Road, La Jolla, California 92037, USA.
T O AkamaTumor Microenvironment, Cancer Center, Sanford-Burnham Medical Research Institute, 10901 North Torrey Pines Road, La Jolla, California 92037, USA.
J PecotteSouthwest National Primate Research Center, Texas Biomedical Research Institute, 7620 NW Loop 410, San Antonio, Texas 78245, USA.
P FrostSouthwest National Primate Research Center, Texas Biomedical Research Institute, 7620 NW Loop 410, San Antonio, Texas 78245, USA.
C BauerSouthwest National Primate Research Center, Texas Biomedical Research Institute, 7620 NW Loop 410, San Antonio, Texas 78245, USA.
J B JimenezSouthwest National Primate Research Center, Texas Biomedical Research Institute, 7620 NW Loop 410, San Antonio, Texas 78245, USA.
J NakayamaDepartment of Molecular Pathology, Shinshu University Graduate School of Medicine, Asahi 3-1-1, Matsumoto 390-8621, Japan.
D AokiDepartment of Obstetrics and Gynecology, Keio University School of Medicine, Shinanomachi 35, Tokyo 160-8582, Japan.
M N FukudaTumor Microenvironment, Cancer Center, Sanford-Burnham Medical Research Institute, 10901 North Torrey Pines Road, La Jolla, California 92037, USA.
Hamamatsu University School of Medicine · JP

Funding

The Southwest National Primate Research Center Supplement- Infrastructure improvements of ABSL2 holding areasP51OD011133 · OD · TEXAS BIOMEDICAL RESEARCH INSTITUTE · PI Larry S. Schlesinger · 2012 to 2026
$129.7M
Tumor Microenvironment and Cancer ImmunologyP30CA030199 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI ELENA B PASQUALE · 1985 to 2026
$107.2M
EXPRESSION AND IN VIVO ROLE OF TROPHININ IN MICER01HD034108 · NICHD · BURNHAM INSTITUTE FOR MEDICAL RESEARCH · PI FUKUDA, MICHIKO N · 1997 to 2002
$686k
NCI NIH HHS P30 CA030199NICHD NIH HHS HD43108NICHD NIH HHS R01 HD034108NIH HHS P51 OD011133
6 · The paper itself

Abstract

Endometriosis is a common gynaecological disease associated with pelvic pain and infertility. Current treatments include oral contraceptives combined with nonsteroidal anti-inflammatory drugs or surgery to remove lesions, all of which provide a temporary but not complete cure. Here we identify an endometriosis-targeting peptide that is internalized by cells, designated z13, using phage display. As most endometriosis occurs on organ surfaces facing the peritoneum, we subtracted a phage display library with female mouse peritoneum tissue and selected phage clones by binding to human endometrial epithelial cells. Proteomics analysis revealed the z13 receptor as the cyclic nucleotide-gated channel β3, a sorting pathway protein. We then linked z13 with an apoptosis-inducing peptide and with an endosome-escaping peptide. When these peptides were co-administered into the peritoneum of baboons with endometriosis, cells in lesions selectively underwent apoptosis with no effect on neighbouring organs. Thus, this study presents a strategy that could be useful to treat peritoneal endometriosis in humans.

Indexed as

Amino Acid SequenceAnimalsApoptosisCyclic Nucleotide-Gated Cation ChannelsDisease Models, AnimalDNA-Binding ProteinsDrug Evaluation, PreclinicalEndometriosisEndometriumEpithelial CellsFemaleHumansMice, Inbred C57BLMolecular Sequence DataMolecular Targeted TherapyPapioCNGB3 protein, humanCyclic Nucleotide-Gated Cation ChannelsDNA-Binding ProteinsPeptide LibraryPeptidesZNF473 protein, human

Identifiers

PMID25047118
PMCPMC4109024
OpenAlexW2063541462

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.